ロード中...
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
Abstract Background Sodium glucose co-transporter2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we investigated the effects of long-term treatment with canagliflozin on bioche...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2018-07-01
|
| シリーズ: | Cardiovascular Diabetology |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s12933-018-0749-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|